|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.680 CNY | -4.06% |
|
-11.60% | -17.26% |
| 26/05 | Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement | MT |
| 25/05 | Guizhou Sanli pharmaceutical to raise funds via private placement | RE |
| Market Cap | 391.79Cr 58Cr 51Cr 47Cr 43Cr 81Cr 5.57TCr 83Cr 561.23Cr 219.26Cr 2.74TCr 217.22Cr 212.54Cr 9.47TCr | P/E 2024 |
19.4x | P/E 2025 | 106x |
|---|---|---|---|---|---|
| Enterprise Value | 426.66Cr 63Cr 55Cr 51Cr 47Cr 89Cr 6.07TCr 90Cr 611.18Cr 238.78Cr 2.98TCr 236.55Cr 231.45Cr 10TCr | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 2.99x |
| Free-Float |
41.88% | Yield 2024 |
2.62% | Yield 2025 | 0.51% |
| 1 day | -4.06% | ||
| 1 week | -11.60% | ||
| Current month | -23.24% | ||
| 1 month | -34.24% | ||
| 3 months | -11.36% | ||
| 6 months | -21.30% | ||
| Current year | -17.26% |
| 1 week | 9.51 |  | 11.05 |
| 1 month | 9.51 | | 14.32 |
| Current year | 9.51 | | 17.46 |
| 1 year | 9.51 | | 17.46 |
| 3 years | 9.51 | | 20.34 |
| 5 years | 9.51 | | 21.28 |
| 10 years | 8.82 | | 44.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Fan Zhang
CEO | Chief Executive Officer | 41 | 27/05/2024 |
Hai Zhang
CEO | Chief Executive Officer | 41 | 01/09/2011 |
Ke Guo
DFI | Director of Finance/CFO | 39 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Hai Zhang
CHM | Chairman | 41 | 01/03/2018 |
Qian Fan Zhang
BRD | Director/Board Member | 41 | 01/03/2018 |
Yong Jian Sheng
BRD | Director/Board Member | 52 | 28/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/09/24 | Sell | Chief Executive Officer | 2,10,00,000 | 5.1428% | ||
| 02/08/24 | Buy | Director | 13,000 | 0.0032% | ||
| 05/08/23 | Sell | 25,000 | 0.0061% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.06% | -11.60% | -24.32% | -38.81% | 58Cr | |
| +0.86% | +1.43% | +48.50% | +160.39% | 1,06700Cr | |
| +1.59% | +4.09% | +55.34% | +53.96% | 63TCr | |
| +0.95% | +1.91% | +35.91% | +81.14% | 46TCr | |
| +1.60% | +6.25% | +33.95% | +29.84% | 35TCr | |
| -0.60% | +1.52% | +35.68% | +39.76% | 30TCr | |
| -0.14% | +0.60% | +16.17% | +17.53% | 26TCr | |
| +0.09% | -2.82% | -28.29% | -41.71% | 22TCr | |
| +1.22% | +2.66% | +21.87% | +59.73% | 20TCr | |
| -1.18% | -3.70% | +14.23% | +66.51% | 16TCr | |
| Average | -0.07% | +0.41% | +20.91% | +42.83% | 36.44TCr | |
| Weighted average by Cap. | +0.55% | +1.95% | +35.80% | +77.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 214.44Cr 32Cr 28Cr 26Cr 24Cr 45Cr 3.05TCr 45Cr 307.18Cr 120.01Cr 1.5TCr 118.89Cr 116.33Cr 5.18TCr | 170.28Cr 25Cr 22Cr 21Cr 19Cr 35Cr 2.42TCr 36Cr 243.93Cr 95Cr 1.19TCr 94Cr 92Cr 4.12TCr |
| Net income | 27Cr 4.05Cr 3.55Cr 3.31Cr 3.03Cr 5.7Cr 389.74Cr 5.79Cr 39Cr 15Cr 191.61Cr 15Cr 15Cr 662.49Cr | 4.63Cr 68.31L 60L 55.8L 51.2L 96.2L 66Cr 97.69L 6.63Cr 2.59Cr 32Cr 2.56Cr 2.51Cr 111.82Cr |
| Net Debt | 11Cr 1.59Cr 1.4Cr 1.3Cr 1.19Cr 2.24Cr 153.13Cr 2.27Cr 15Cr 6.03Cr 75Cr 5.97Cr 5.84Cr 260.29Cr | 35Cr 5.15Cr 4.52Cr 4.21Cr 3.86Cr 7.25Cr 495.96Cr 7.36Cr 50Cr 20Cr 243.83Cr 19Cr 19Cr 843.04Cr |
Employees
1,887
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | CN¥9.680 | -4.06% | 68,58,700 |
| 23/26/23 | CN¥10.09 | +1.61% | 77,06,800 |
| 22/26/22 | CN¥9.930 | -1.97% | 1,23,12,000 |
| 21/26/21 | CN¥10.13 | -3.52% | 1,85,42,500 |
| 20/26/20 | CN¥10.50 | -4.11% | 1,42,69,400 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603439 Stock
Select your edition
All financial news and data tailored to specific country editions
